Поисковый запрос: (<.>A=Estrov, Zeev$<.>) |
Общее количество найденных документов : 35
Показаны документы с 1 по 20
|
|
1.
| Применение децитабина при миелодиспластическом синдроме низкого или промежуточного риска: рандомизированного открытое исследование II фазы // J. Clin. Oncol., 2013. Т. 7, N 3.-С.264
|
2.
| Применение децитабина при миелодиспластическом синдроме низкого или промежуточного риска: рандомизированного открытое исследование II фазы // J. Clin. Oncol., 2013. Т. 7, N 3.-С.264
|
3.
| WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute meyloid leukemia (AML) // Anticancer Res., 2005. Vol. 25, N 3B.-С.1841-1850
|
4.
| WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute meyloid leukemia (AML) // Anticancer Res., 2005. Vol. 25, N 3B.-С.1841-1850
|
5.
| WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute meyloid leukemia (AML) // Anticancer Res., 2005. Vol. 25, N 3B.-С.1841-1850
|
6.
| Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission // Brit. J. Haematol., 2002. Vol. 117, N 4.-С.869-874
|
7.
| Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission // Brit. J. Haematol., 2002. Vol. 117, N 4.-С.869-874
|
8.
| The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells // Invest. New Drugs, 2011. Vol. 29, N 6.-С.1206-1212
|
9.
| The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells // Invest. New Drugs, 2011. Vol. 29, N 6.-С.1206-1212
|
10.
| The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells // Invest. New Drugs, 2011. Vol. 29, N 6.-С.1206-1212
|
11.
| Is acute myeloid leukemia a liquid tumor? // Int. J. Cancer, 2013. Vol. 133, N 3.-С.534-543
|
12.
| Is acute myeloid leukemia a liquid tumor? // Int. J. Cancer, 2013. Vol. 133, N 3.-С.534-543
|
13.
| Interleukin-7 receptor-'альфа' gene mutations are not detected in adult T-cell acute lymphoblastic leukemia // Cancer Med., 2014. Vol. 3, N 3.-С.550-554
|
14.
| Interleukin-7 receptor-'альфа' gene mutations are not detected in adult T-cell acute lymphoblastic leukemia // Cancer Med., 2014. Vol. 3, N 3.-С.550-554
|
15.
| Interleukin-3 // Amer. J. Clin. Oncol., 1991. Vol. 14, Suppl. N1.-С.S45-S50
|
16.
| Homoharringtonine (HHT) produces high response rates in Philadelphia chromosome positive (Ph{1}) chronic myelogenous leukemia (CML) // Blood, 1991. Vol. 78, N 10 Suppl. N1.-С.170
|
17.
| Halperin Daniel S. Diamond-Blackfan anemia: promotion of marrow erythropoiesis in vitro by recombinant interleukin-3 // Blood, 1989. Vol. 73, N 5.-С.1168-1174
|
18.
| Estrov Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay // Cancer Res., 1988. Vol. 48, N 20.-С.5901-5907
|
19.
| Estrov Acute lymphoblastic leukemia blast cells do not inhibit bone marrow hematopoietic progenitor colony formation // Exp. Hematol., 1991. Vol. 19, N 3.-С.221-225
|
20.
| E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway // Clin. Cancer Res., 2000. Vol. 6, N 1.-С.250-259
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"